This pilot study analyzes the cost savings of utilizing a prescription medical food, serum-derived bovine immunoglobulin/protein isolate, for the management of inflammatory bowel disease in a small cohort.
Patricia Burgunder, ARNP
Advertisement
Articles by Patricia Burgunder, ARNP
Advertisement
Latest Updated Articles
- Pilot Pharmacoeconomic Analysis of Serum-derived Bovine Immunoglobulin Use in IBD
Published: April 20th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Common Virus May Hold New Clues to Lupus
2
Zongertinib Shows Clinically Meaningful Efficacy in Advanced HER2-Mutant NSCLC
3
Expert Discusses Logistical Considerations and Future Research Needs for Radiopharmaceuticals
4
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
5
